BioCell Innovations Pte Ltd has recently signed a Memorandum of Understanding with Thermo Fisher Scientific Pte Ltd (a subsidiary of Thermo Fisher Scientific Inc) aiming to optimize a closed process for the clinical manufacturing of lentiviral-based immunotherapies within the Asia-Pacific region. We are excited to collaborate and to support new
Conference (Poster) Presentation Period Title of Presentation Singapore Cell and Gene Therapy Pan Asia Summit, Singapore Jul 2024 Accelerated CD19 CAR T-cell Manufacturing with Enhanced Vector Transduction and Reduced Risk of CRS American Society of Gene and Cell Therapy, USA May 2023 A six-day enhanced clinical scale manufacturing of transduced